Bone loss associated with use of antiepileptic drugs

Bibliography

• Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003;16(2):165-70
   PubMed Web of Science ®Google Scholar
• Svendsen T, Lossius M, Nakken KO. Age-specific prevalence of epilepsy in Oppland County, Norway. Acta Neurol Scand 2007;116(5):307-11
   PubMed Web of Science ®Google Scholar
• Sheth RD. Metabolic concerns associated with antiepileptic medications. Neurology 2004;63:S24-9
   PubMed Web of Science ®Google Scholar
• Mattson RH, Gidal BE. Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav 2004;5:S36-40
   PubMed Web of Science ®Google Scholar
• Pedersen KK, Christiansen C, Ahlgren P, Incidence of fractures of the vertebral spine in epileptic patients. Acta Neurol Scand 1976;54(2):200-3
   PubMed Web of Science ®Google Scholar
• Sheth RD. Bone health in pediatric epilepsy. Epilepsy Behav 2004;5:S30-5
   PubMed Web of Science ®Google Scholar
• Fitzpatrick LA. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav 2004;5:S3-15
   Web of Science ®Google Scholar
• Valsamis HA, Arora SK, Labban B, Antiepileptic drugs and bone metabolism. Nutr Metab (Lond) 2006;3:36
   PubMedGoogle Scholar
• Pack AM, Walczak TS. Bone health in women with epilepsy: clinical features and potential mechanisms. Int Rev Neurobiol 2008;83:305-28
   PubMed Web of Science ®Google Scholar
• Drezner MK. Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 2004;5:S41-7
   PubMed Web of Science ®Google Scholar
• Pack AM, Morrell MJ. Epilepsy and bone health in adults. Epilepsy Behav 2004;5:S24-9
   PubMed Web of Science ®Google Scholar
• Sheth RD. Bone health in epilepsy. Lancet Neurol 2004;3(9):516
   PubMed Web of Science ®Google Scholar
• Pothiwala P, Evans EM, Chapman-Novakofski KM. Ethnic variation in risk for osteoporosis among women: a review of biological and behavioral factors. J Womens Health (Larchmt) 2006;15(6):709-19
   PubMed Web of Science ®Google Scholar
• Lofthus CM, Osnes EK, Falch JA, Epidemiology of hip fractures in Oslo, Norway. Bone 2001;29(5):413-8
   PubMed Web of Science ®Google Scholar
• Elliott JO. Possible methods for the prevention of bone loss in persons with epilepsy. Expert Rev Neurother 2009;9(6):797-812
   PubMed Web of Science ®Google Scholar
• Tucker KL. Osteoporosis prevention and nutrition. Curr Osteoporos Rep 2009;7(4):111-7
   PubMedGoogle Scholar
• Pack A. Bone health in people with epilepsy: is it impaired and what are the risk factors? Seizure 2008;17:181-6
   PubMed Web of Science ®Google Scholar
• Kok C, Sambrook PN. Secondary osteoporosis in patients with an osteoporotic fracture. Best Pract Res Clin Rheumatol 2009;23(6):769-79
   PubMed Web of Science ®Google Scholar
• Valmadrid C, Voorhees C, Litt B, Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol 2001;58:1369-74
   PubMed Web of Science ®Google Scholar
• Epilepsy Action (UK). Anti-epileptic drugs and the risk of osteoporosis and osteomalcia: how much information do patients taking anti-epileptic drugs feel they receive about side effects of this medication? British Epilepsy Association, Leeds, UK; 2003
   Google Scholar
• Landmark CJ. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs 2008;22(1):27-47
   PubMed Web of Science ®Google Scholar
• Bergqvist AGC, Schall JI, Stallings VA, Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogen diet. Am J Clin Nutr 2008;88:1678-84
   PubMed Web of Science ®Google Scholar
• Elliott ME, Binkley N. Evaluation and measurement of bone mass. Epilepsy Behav 2004;5:S16-23
   PubMed Web of Science ®Google Scholar
• WHO Study Group. Assessment of fracture risk and its application to screening of postmenopausal osteoporosis. Genève: WHO Technical Report Series, No. 843: 1994
   Google Scholar
• Looker AC, Bauer DC, Chesnut CH III, Clinical use of biochemical markers of bone remodelling: current status and future directions. Osteoporos Int 2000;11:467-80
   PubMed Web of Science ®Google Scholar
• Pack AM, Morrell MJ. Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications. CNS drugs 2001;15(8):633-42
   PubMed Web of Science ®Google Scholar
• Souverein PC, Webb DJ, Weil JG, Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology 2006;66(9):1318-24
   PubMed Web of Science ®Google Scholar
• Coppola G, Fortunato D, Auricchio G, Bone mineral density in children, adolescents, and young adults with epilepsy. Epilepsia 2009;50(9):2140-6
   PubMed Web of Science ®Google Scholar
• Ensrud KE, Walczak TS, Blackwell T, Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology 2004;62:2051-7
   PubMed Web of Science ®Google Scholar
• Richens A, Rowe DJ. Disturbance of calcium metabolism by anticonvulsant drugs. BMJ 1970;4(5727):73-6
   PubMed Web of Science ®Google Scholar
• Vestergaard P. Epilepsy, osteoporosis and fracture risk – meta-analysis. Acta Neurol Scand 2005;112(5):277-86
   PubMed Web of Science ®Google Scholar
• Persson HB, Alberts KA, Farahmand BY, Risk of extremity fractures in adult outpatients with epilepsy. Epilepsia 2002;43:768-72
   PubMed Web of Science ®Google Scholar
• Koppel BS, Harden CL, Nikolov BG, An analysis of lifetime fractures in women with epilepsy. Acta Neurol Scand 2005;111(4):225-8
   PubMed Web of Science ®Google Scholar
• Vanheer P, van Rhijn J, Boel M, Supracondylar femur fracture complicating epileptic insult: a specific and under diagnosed complication? Acta Neurol Belg 2008;108(1):17-20
   PubMed Web of Science ®Google Scholar
• Pappademos PC, Hamilton WG. Bilateral displaced femoral neck fractures after myoclonic seizures treated with bilateral total hip arthroplastics. Am J Orthop 2009;38(2):88-9
   PubMedGoogle Scholar
• Wirrell EC. Epilepsy-related injuries. Epilepsia 2006;47(Suppl 1):79-86
   PubMedGoogle Scholar
• Nakken KO, Lossius R. Seizure-related injuries in multihandicapped patients with therapy-resistant epilepsy. Epilepsia 1993;34:836-40
   PubMed Web of Science ®Google Scholar
• Dubost JJ, Vernay D, Soubrier M, Vertebral compression in epilepsy. Analysis of 8 cases. Rev Med Intern 1993;14(5):294-6
   PubMed Web of Science ®Google Scholar
• McCullen GM, Brown CC. Seizure-induced thoracic burst fractures. A case report. Spine 1994;19(1):77-9
   PubMed Web of Science ®Google Scholar
• Youssef JA, McCullen GM, Brown CC. Seizure-induced lumbar burst fracture. Spine 1995;20(11):1301-3
   PubMed Web of Science ®Google Scholar
• Gnanalingham K, Maconovic M, Joshi S, Non-traumatic compression fractures of the thoracic spine following a seizure – treatment by percutaneous kyphoplasty. Minim Invasiv Neurosurg 2004;47(4):256-7
   PubMed Web of Science ®Google Scholar
• Beerhorst K, Huvers FC, Renier WO. Severe early onset osteopenia and osteoporosis caused by antiepileptic drugs. Neth J Med 2005;63(6):222-6
   PubMed Web of Science ®Google Scholar
• Aboukasm AG, Smith BJ. Nocturnal vertebral compression fracture. A presenting feature of unrecognized epileptic seizures. Arch Fam Med 1997;6(2):185-7
   PubMedGoogle Scholar
• Roohi F, Fox A. Burst fracture of the first lumbar vertebra and conus-cauda syndrome complicating a single convulsive seizure: a challenge of diagnosis in the Emergency Department. J Emerg Med 2006;31(4):381-5
   PubMed Web of Science ®Google Scholar
• Stephen LJ, McLellan AR, Harrison JH, Bone density and antiepileptic drugs: a case-controlled study. Seizure 1999;8(6):339-42
   PubMed Web of Science ®Google Scholar
• Sheth RD, Binkley N, Hermann BP. Progressive bone loss in epilepsy. Neurology 2008;70(3):170-6
   PubMed Web of Science ®Google Scholar
• Phabphal K, Geater A, Leelawattana R, Prevalence and risk factors of low bone mineral density and 25-hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drugs. Bone 2009;45(2):232-7
   PubMed Web of Science ®Google Scholar
• Valimaki MJ, Tiihonen M, Laitinen K, Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res 1994;9(5):631-7
   PubMed Web of Science ®Google Scholar
• Pack AL, Morrell MJ, Marcus R, Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 2005;57:252-7
   PubMed Web of Science ®Google Scholar
• Verotti A, Greco G, Morese G, Increased bone turnover in epileptic patients treated with carbamazepine. Ann Neurol 2000;47:385-8
   PubMed Web of Science ®Google Scholar
• Sato Y, Kondo I, Ishida S, Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 2001;57:445-9
   PubMed Web of Science ®Google Scholar
• Ecevit C, Aydogan A, Kavakli T, Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol 2004;31(4):279-82
   PubMed Web of Science ®Google Scholar
• Boluk A, Guzelipek M, Savli H, The effect of valproate on bone mineral density in adult epileptic patients. Pharmacol Res 2004;50(1):93-7
   PubMed Web of Science ®Google Scholar
• Mintzer S, Boppana P, Toguri J, Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 2006;47(3):510-5
   PubMed Web of Science ®Google Scholar
• Cetinkaya Y, Kurtulmus YS, Tutkavul K, The effect of oxcarbazepine on bone metabolism. Acta Neurol Scand 2009;120:170-5
   PubMed Web of Science ®Google Scholar
• Guo C-Y, Ronen GM, Atkinson SA. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia 2001;42:1141-7
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee JW, Choi KG, A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav 2007;10(2):291-5
   PubMed Web of Science ®Google Scholar
• Leung A, Ramsay E. Effect of topiramate on bone resorption in adults [abstract]. Am Epilepsy Soc 2006;2:150
   Google Scholar
• Nissen-Meyer LSH, Svalheim S, Taubøll E, Levetiracetam, phenytoin and valproate act differently on rat bone mass, structure and metabolism. Epilepsia 2007;48(10):1850-60
   PubMed Web of Science ®Google Scholar
• Hunter J, Maxwell JD, Stewart DA, Altered calcium metabolism in epileptic children on anticonvulsants. BMJ 1971;4(5781):202-4
   PubMed Web of Science ®Google Scholar
• Bouillon R, Reynaert J, Claes JH, The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. J Clin Endocrinol Metab 1975;41(06):1130-5
   PubMedGoogle Scholar
• Gough H, Goggin T, Bissessar A, A comparative study of the relative influence og different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med 1986;59(230):569-77
   PubMedGoogle Scholar
• Hoikka V, Savolainen K, Esko M, Osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy. Acta Neurol Scand 1981;64:122-31
   PubMed Web of Science ®Google Scholar
• Bogliun G, Beghi E, Crespi V, Anticonvulsant drugs and bone metabolism. Acta Neurol Scand 1986;74:284-8
   PubMed Web of Science ®Google Scholar
• El-Hajj Fuleihan G, Dib L, Yamout B, Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone 2008;43(1):149-55
   PubMed Web of Science ®Google Scholar
• Lyngstad-Brechan MA, Taubøll E, Nakken KO, Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy. Scand J Clin Lab Invest 2008;68:759-66
   PubMed Web of Science ®Google Scholar
• Farhat G, Yamout B, Mihati MA, Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;58:1348-53
   PubMed Web of Science ®Google Scholar
• Hahn TJ, Hendin BA, Scharp CR, Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med 1972;287:900-4
   PubMed Web of Science ®Google Scholar
• Stamp TC, Round JM, Rowe DJ, Plasma levels and therapeutic effect of 25-hydroxycholecalceferol in epileptic patients taking anticonvulsant drugs. BMJ 1972;4(5831):9-12
   PubMed Web of Science ®Google Scholar
• Tjellesen L, Christiansen C. Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants. Acta Neurol Scand 1982;66(3):335-41
   PubMed Web of Science ®Google Scholar
• Gaitatzis A, Carroll K, Majeed A, The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004;45(12):1613-22
   PubMed Web of Science ®Google Scholar
• Sheth RD, Gidal BE, Hermann BP. Pathological fractures in epilepsy. Epilepsy Behav 2006;9(4):601-5
   PubMed Web of Science ®Google Scholar
• Andress DL, Ozuna J, Tirschwell D, Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 2002;59:781-6
   PubMed Web of Science ®Google Scholar
• Annegers JF, Melton LJ, Sun CA, Risk of age-related fractures in patients with unprovoked seizures. Epilepsia 1989;30:348-55
   PubMed Web of Science ®Google Scholar
• Cummings S, Nevitt M, Browner W, Risk factors for hip fractures in white women. N Engl J Med 1995;332:767-73
   PubMed Web of Science ®Google Scholar
• Souverein PC, Webb DJ, Petri H, Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database. Epilepsia 2005;46(2):304-10
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia 2004;45(11):1330-7
   PubMed Web of Science ®Google Scholar
• Tsiropoulos I, Andersen M, Nymark T, Exposure to antiepileptic drugs and the risk of hip fracture: a case-control study. Epilepsia 2008;49(12):2092-9
   PubMed Web of Science ®Google Scholar
• Vestergaard P. Epilepsy, osteporosis and fracture risk – meta-analysis. Acta Neurol Scand 2005;112(5):277-86
   PubMed Web of Science ®Google Scholar
• Sheth RD, Wesolowski CA, Jacob JC, Effect of carbamazepine and valproate on bone mineral density. J Pediatr 1995;127:256-62
   PubMed Web of Science ®Google Scholar
• Feldkamp J, Becker A, Witte OW, Long-term anticonvulsant therapy leads to low bone mineral density–evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. Exp Clin Endocrin Diab 2000;108:37-43
   PubMed Web of Science ®Google Scholar
• Petty SJ, O'Brien TJ, Wark JD. Anti-epileptic medication and bone health. Osteoporos Int 2007;18:129-42
   PubMed Web of Science ®Google Scholar
• Koch HV, Kraft D, von Herrath D. Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat. Epilepsia 1972;13:829-41
   PubMed Web of Science ®Google Scholar
• Corradino RA. Diphenylhydantoin: direct inhibition of the vitamin D3-mediated calcium absorptive mechanism in organ-cultured duodenum. Biochem Pharmacol 1976;25:863-4
   PubMed Web of Science ®Google Scholar
• Bell RD, Pak CY, Zerwekh J, Effect of phenytoin on bone and vitamin D metabolism. Ann Neurol 1979;5:374-8
   PubMed Web of Science ®Google Scholar
• Hahn TJ, Hendin BA, Scharp CR, Serum 25-hydroxy calciferol levels and bone mass in children on chronic antiepileptic therapy. N Engl J Med 1975;292:550-4
   Web of Science ®Google Scholar
• Kruse S, Suss A, Busse M, Monometric serum calcitonin and bone turnover during anticonvulsant treatment and in congenital hypothyroidism. J Pediatr 1987;111:57-63
   PubMed Web of Science ®Google Scholar
• Vernillo AT, Rifkin BR, Hauschka PV. Phenytoin affects osteoblastic secretion from osteoblastic rat osteosarcoma 17/2.8 cells in culture. Bone 1990;11:309-11
   PubMed Web of Science ®Google Scholar
• Pento JT, Hurt GM, Rajah T. Evaluation of calcium-mediated calcitonin secretion from the isolated pefused porcine thyroid using secretory inhibitors. Horm Metab Res 1996;27:107-9
   Web of Science ®Google Scholar
• Onodera K, Takahashi A, Sakurada S, Effects of phenytoin and/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats. Life Sci 2002;70:1533-42
   PubMed Web of Science ®Google Scholar
• Gracious B, Bossert RP, Puzas JE. Valproic acid inhibits osteoblast and osteoclast activity in therapeutic dose ranges. J Bone Miner Res 2004;M405(Suppl): abstract
   Google Scholar
• Schroeder TM, Westendorf JJ. Histone deacetylase inhibitors promote osteoblast maturation. J Bone Miner Res 2005;20:2254-63
   PubMed Web of Science ®Google Scholar
• Kumandas S, Koklu E, Gümüs H, Effect of carbamazepine and valproic acid on bone mineral density, IGF-1 and IGFBP-3. J Pediatr Endocrinol Metab 2006;19(4):529-34
   PubMed Web of Science ®Google Scholar
• Isojärvi J. Disorders of reproduction in patients with epilepsy: antiepileptic drug related mechanisms. Seizure 2008;17:111-9
   PubMed Web of Science ®Google Scholar
• Taubøll E, Røste LS, Svalheim S, Disorders of reproduction in epilepsy – what can we learn from animal studies? Seizure 2008;17(2):120-6
   PubMed Web of Science ®Google Scholar
• Rattya J, Pakarinen AJ, Knip M, Early hormonal changes during valproate or carbamazepine treatment: a 3-month study. Neurology 2001;57(3):440-4
   PubMed Web of Science ®Google Scholar
• Taubøll E, Gregoraszczuk EL, Kolodzeij A, Valproate inhibits the conversion of testosterone to estradiol and acts as an apoptotic agent in growing porcine ovarian follicular cells. Epilepsia 2003;44(8):1014-21
   PubMed Web of Science ®Google Scholar
• Røste LS, Taubøll E, Isojärvi JIT, Effects of chronic valproate treatment on reproductive endocrine hormones in female and male Wistar rats. Reprod Toxicol 2002;16:767-73
   PubMed Web of Science ®Google Scholar
• Taubøll E, Gregorasczuk EL, Wojtowicz AK, Effects of levetiracetam and valproate on reproductive endocrine function studied in human ovarian follicular cells. Epilepsia 2009;50(8):1868-74
   PubMed Web of Science ®Google Scholar
• Apeland T, Mansoor M, Strandjord RE. Antiepileptic drugs as independent predictors of plasma total homocystein levels. Epilepsy Res 2001;47:27-35
   PubMed Web of Science ®Google Scholar
• McLean RR, Jacques PF, Selhub J, Homocysteine as a predictive factor for hip fractures in older persons. N Engl J Med 2004;350:2042-51
   PubMed Web of Science ®Google Scholar
• Elliott JO, Jacobson MP, Haneef Z. Homocysteine and bone loss in epilepsy. Seizure 2007;16:22-34
   PubMed Web of Science ®Google Scholar
• Schroeder TM, Nair AK, Staggs R, Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors. BMC Genomics 2007;8:362
   PubMed Web of Science ®Google Scholar
• Hamed SA, Abdella MM. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status. Epilepsy Res 2009;86(1):32-41
   PubMed Web of Science ®Google Scholar
• Anil M, Helvaci M, Ozbal E, Serum and muscle carnitine levels in epileptic children receiving sodium valproate. J Child Neurol 2009;24(1):80-6
   PubMed Web of Science ®Google Scholar
• Hooshmand S, Balakrishnan A, Clark RM, Dietary l-carnitine supplementation improves bone mineral density by suppressing bone turnover in aged ovariectomized rats. Phytomedicine 2008;15(8):595-601
   PubMed Web of Science ®Google Scholar
• Volpe SI, Schall JI, Gallagher PR, Nutrient intake of children with intractable epilepsy compared with healthy children. J Am Diet Assoc 2007;107(6):1014-18
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med 2007;357(3):266-81
   PubMed Web of Science ®Google Scholar
• Bjørholt PG, Nakken KO, Røhme K, Leisure time habits and physical fitness in adults with epilepsy. Epilepsia 1990;31(1):83-7
   PubMed Web of Science ®Google Scholar
• Dubow JS, Kelly JP. Epilepsy in sports and recreation. Sports Med 2003;33(7):499-516
   PubMed Web of Science ®Google Scholar
• Nakken KO. Physical exercise in outpatients with epilepsy. Epilepsia 1999;40(5):643-51
   PubMed Web of Science ®Google Scholar
• Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000;289(5484):1501-4
   PubMed Web of Science ®Google Scholar
• Karsenty G. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 2006;4:341-8
   PubMed Web of Science ®Google Scholar
• Bhatt R, Bhatt S, Hameed M, Amygdaloid kindled seizures can induce functional and pathological changes in thymus of rat: role of sympathetic nervous system. Neurobiol Dis 2006;21(1):127-37
   PubMed Web of Science ®Google Scholar
• Harden CL, Herzog AG, Nikolov BG, Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study. Epilepsia 2006;47(9):1447-51
   PubMed Web of Science ®Google Scholar
• Elliott JO, Lu B, Moore JL, Exercise, diet, health behaviors, and risk factors among persons with epilepsy based on California Health Interview Survey, 2005. Epilepsy Behav 2008;13(2):307-15
   PubMed Web of Science ®Google Scholar